1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsSenior Center Capital Grants is sponsored by Tennessee Department of Disability and Aging (DDA). These competitive grants support senior centers in providing older adults with access to resources, activities, and social connection. Funding is encouraged for capital projects, including building improvements and equipment.
Get alerted about grants like this
Get emailed when new opportunities from “Tennessee Department of Disability and Aging (DDA)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
DDA Providing $5 Million in Grant Funding to Senior Centers Register for the State Conference on Aging DDA Providing $5 Million in Grant Funding to Senior Centers Tuesday, June 09, 2026 | 12:00pm The Department of Disability and Aging (DDA) will be accepting applications for competitive grant funding for senior centers.
This one-time grant funding is intended to support senior centers in providing older adults with access to resources, activities and social connections. The Tennessee General Assembly has provided $5 million to be distributed to senior centers throughout the state.
This year marks the sixth consecutive year of funding through the Tennessee General Assembly to support the vital work of senior centers in improving the lives of older adults in their communities. “Senior centers provide life saving resources to older adults across the Volunteer State,” said DDA Commissioner Brad Turner.
“We’re proud to see the legislature recognize how vital senior centers are to providing physical, emotional and mental nourishment to Tennessee’s growing aging population. Grant funding will allow for updated equipment, upgraded facilities and exciting programming that help senior centers, and entire communities, thrive. ” Senior centers are invited to apply for grant funding ranging from $5,000 to $50,000.
The grant funding is encouraged to fund the following goals: Capital Projects, including building improvements and equipment Routine Operating Expenses, not including staff salaries In order to qualify for grant funding, the organization must meet the following definition of a senior center: A non-residential community facility for the organization and provision of a broad spectrum of services which shall include provision of health (including mental and behavioral health), social, nutritional, and educational services and the provision of facilities for recreational activities for older individuals, including as provided via virtual facilities; and Be an organization with established programming that provides a minimum of 16 hours a month of activities or services specifically targeted for adults 60 and over.
The grant is not available to individuals or to long-term care and assisted living facilities. Applications will open for submission on June 22, 2026. Applications must be received no later than 4:00 p.
m. Central Time on Friday, August 7, 2026. Grant funding must be spent by March 31, 2028.
Learn more about the grants at the DDA website: https://www. tn. gov/content/tn/disability-and-aging/resource-directory/grants.
html
According to the current listing, eligibility includes: Senior centers in Tennessee. Confirm the full requirements in the official notice before applying.
The current listing shows $5,000 to $50,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was August 7, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Senior Center Capital Grants is funded by Tennessee Department of Disability and Aging (DDA). Verify program details on the funder's official page before applying.
This opportunity targets applicants in Tennessee. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward advances in AI and data science for biomedical and public health research. Projects must cross disciplinary boundaries.
Tennessee's $206.9M RHTP allocation begins distribution with a 30-day virtual maternal/child mental health consultation grant. The state plans a new opportunity every Friday — the cadence and structure here are the blueprint for how the $50B nationwide program rolls out.
Read articleSeven research teams will run the first clinical trials aimed at extending human healthspan under ARPA-H PROSPR contracts worth up to $144M. The milestone-based contract model breaks every convention of federal biomedical funding.
Read articleARPA-H PROSPR program funds seven research teams up to $144M to develop the first clinical trials targeting biological aging itself, testing rapamycin analogs, semaglutide, and retrotransposon inhibitors.
Read article